Bioquímicos e reagentes
Os bioquímicos e reagentes são substâncias fundamentais para a pesquisa e desenvolvimento em campos como biotecnologia, biologia molecular, farmacologia e medicina. Esses produtos são essenciais para uma variedade de aplicações, incluindo a síntese de compostos, a análise de amostras biológicas, a pesquisa de processos metabólicos e a produção de medicamentos. Na CymitQuimica, oferecemos uma ampla seleção de bioquímicos e reagentes de alta qualidade e pureza, adequados para diversas necessidades científicas e industriais. Nosso catálogo inclui enzimas, anticorpos, ácidos nucleicos, aminoácidos e muitos outros produtos, todos projetados para apoiar pesquisadores e profissionais em seus projetos de pesquisa e desenvolvimento, garantindo resultados confiáveis e reproduzíveis.
Subcategorias de "Bioquímicos e reagentes"
- Biomoléculas(99.117 produtos)
- Por Alvo Biológico(99.161 produtos)
- Por uso/Efeitos Farmacológicos(6.787 produtos)
- Compostos relacionados à criopreservação e aos crioconservantes(21 produtos)
- Desinfetantes, aditivos para aquecimento de líquidos de banho e compostos relacionados(28 produtos)
- Hormónios(346 produtos)
- Biologia Vegetal(6.705 produtos)
- Metabólitos secundários(14.220 produtos)
Foram encontrados 130581 produtos de "Bioquímicos e reagentes"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
C-Reactive Protein (CRP) (77-82)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C23H40N6O10Peso molecular:560.61 g/molP61 (343-355), M. leprae
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C62H107N21O24Peso molecular:1,530.67 g/molMilvexian
CAS:<p>Milvexian is a peptide that binds to the receptor site of NMDA ion channels, inhibiting the flow of ions and leading to neuronal cell death. The molecular weight of Milvexian is 609 amu and its chemical formula is C28H40N2O2. It is used as a research tool in Cell Biology, pharmacology, and protein interactions. Milvexian has been shown to be an inhibitor for many ligands, including GABA, L-glutamate, excitatory amino acids and neuropeptides.</p>Fórmula:C28H23Cl2F2N9O2Pureza:Min. 95%Peso molecular:626.4 g/molPRRS-PQGAB-N
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C54H76N12O24SPeso molecular:1,309.33 g/molβ-MSH, porcine
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C98H138N26O29SPeso molecular:2,176.36 g/molInsulin-like Growth Factor I (57-70)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C65H104N15O23SPeso molecular:1,495.7 g/molβ-Amyloid/A4 Protein Precursor (APP) (96-110), analog
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C81H128N32O19S2Peso molecular:1,918.25 g/molTRAP-6 amide trifluoroacetate salt
CAS:<p>Protease-activated receptor 1 (PAR-1) selective activating peptide, TFA salt. 98%.</p>Fórmula:C34H57N11O8Pureza:Min. 95%Cor e Forma:PowderPeso molecular:747.89 g/molEGF Receptor Substrate 1
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C72H100N15O26PPeso molecular:1,622.68 g/molOrcokinin
CAS:<p>Orcokinin H-Asn-Phe-Asp-Glu-Ile-Asp-Arg-Ser-Gly-Phe-Gly-Phe is a peptide that was synthesized in the laboratory. It has been shown to have receptor activity and to stimulate locomotor activity in experimental models. Orcokinin H is a member of the family of peptide hormones that are present in mammals. The peptide sequence contains six amino acids, four of which are hydrophobic and two polar, with a single hydroxyl group. These features make this molecule an excellent candidate for use as a model system for studying amyloid protein aggregation and its physiological function.</p>Fórmula:C67H92N18O23Pureza:Min. 95%Peso molecular:1,517.55 g/molTNF-α(10-36) (human)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C131H211N43O38Peso molecular:2,996.41 g/molPanaxynol
CAS:<p>Panaxynol is an active compound that belongs to the group of polyphenols. It has been shown to inhibit nuclear DNA synthesis in human leukemic HL-60 cells. This inhibition is due to its ability to bind with the dextran sulfate moiety of DNA, thereby preventing DNA synthesis. Panaxynol also has antibacterial efficacy against gram-positive bacteria and significant cytotoxic effects on HL-60 cells.</p>Fórmula:C17H24OPureza:Min. 95%Cor e Forma:Clear LiquidPeso molecular:244.37 g/molCaspase 3 Substrate, chromogenic
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C27H39N7O10Peso molecular:621.66 g/molInfluenza A M2 coat protein (22-46)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C129H215N31O33Peso molecular:2,728.34 g/molPRRS-PQGAB-M
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C53H80N16O23Peso molecular:1,309.32 g/molSecretin-Lys(Biotin), human
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C130H220N44O40Peso molecular:3,039.4 g/molP38 (411-425), M. leprae
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C59H100N16O20Peso molecular:1,353.55 g/mol[Pyr11]-Amyloid β-Protein (11-40)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C143H226N38O39SPeso molecular:3,133.71 g/mol[Ala2] Met-Enkephalin, amide
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C28H38N6O6SPeso molecular:586.72 g/molβ-Amyloid/A4 Protein Precusor (APP) (319-335)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C86H151N31O26S2Peso molecular:2,099.48 g/molLHRH-Ⅲ, lamprey
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C59H75N18O14Peso molecular:1,259.4 g/molC-Myc peptide epitope
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C51H86N12O21Peso molecular:1,203.32 g/molNES Topoisomerase II α (1017-1028)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C73H117N19O19Peso molecular:1,564.86 g/mol2B/3, Dengue Protease Substrate
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C41H58N14O12Peso molecular:949.09 g/molTRH-SH Pro
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C48H85N21O12S2Peso molecular:1,212.46 g/molDynorphin A amide, porcine
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C99H156N32O22Peso molecular:2,146.55 g/molMBP (90-106)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C91H143N25O23Peso molecular:1,955.31 g/molα-Endorphin
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C77H120N18O26SPeso molecular:1,745.98 g/molCalcineurin Autoinhibitory Fragment
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C124H205N39O39S2Peso molecular:2,930.38 g/mol[Des-Gln16]-PACAP (6-27), amide, human, ovine, rat
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C116H185N31O29SPeso molecular:2,510 g/molβ I probe
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C81H116N26O24Peso molecular:1,873.99 g/molPancreatic Polypeptide (31-36) (free acid) (human)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C36H60N12O9Peso molecular:805 g/molMelanotan II, MT-Ⅱ
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C50H69N15O9Peso molecular:1,024.2 g/molα-Bag Cell Peptide (1-8)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C47H72N14O11Peso molecular:1,009.19 g/mol[Asn76] PTH (64-84), human
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C94H163N27O35Peso molecular:2,231.51 g/molEp-CAM (263-271)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C38H70N10O10Peso molecular:827.04 g/molHuman CMV Assemblin Protease Substrate (M-site)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C52H96N20O16Peso molecular:1,257.47 g/molACTH(4-9), Tyr
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C53H68N14O12SPeso molecular:1,125.28 g/molgp100 (178-187)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C42H71N11O14S2Peso molecular:1,018.23 g/molCorticotropin Releasing Factor, human, rat
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C208H344N60O63S2Peso molecular:4,757.44 g/molPRRS-PQGAB-C
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C67H90N16O19Peso molecular:1,423.56 g/molBiotin-Pancreatic Polypeptide, human
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C195H301N55O56S3Peso molecular:4,407.99 g/molα-Gliadin (57-73)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C93H136N22O27Peso molecular:1,994.25 g/molMBP (74-85), guinea pig
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C56H94N20O23Peso molecular:1,415.49 g/molCC Chemokine Receptor 3 Fragment II, amide
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C114H175N25O42S2Peso molecular:2,631.93 g/molα-Mating Factor (1-6)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C45H59N11O8Peso molecular:882.04 g/molMRTX849
CAS:<p>MRTX849 is a small molecule inhibitor, which is derived through rational drug design targeting specific oncogenic mutations. It acts as a covalent inhibitor that selectively targets the KRAS G12C mutation, a prevalent alteration in various cancers such as non-small cell lung cancer and colorectal cancer. The mode of action involves binding to the mutated KRAS G12C protein, locking it in an inactive GDP-bound state, thereby inhibiting downstream signaling pathways crucial for tumor cell proliferation and survival.</p>Fórmula:C32H35ClFN7O2Pureza:Min. 95%Peso molecular:604.12 g/molCalcitonin N-Terminal Flanking Peptide, human
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C264H426N74O97SPeso molecular:6,220.84 g/molIGF-I (30-41)
CAS:<p>Please enquire for more information about IGF-I (30-41) including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Fórmula:C51H83N19O19Pureza:Min. 95%Peso molecular:1,266.32 g/molβ-Amyloid (15-21)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C43H65N9O9Peso molecular:852.05 g/mol[D-Arg1,D-Pro2,D-Phe7,D-His9]-Substance P
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C67H102N20O13SPeso molecular:1,427.75 g/molH-D-Ile-OBzl·p-tosylate
CAS:<p>H-D-Ile-OBzl·p-tosylate is a synthetic compound that has been found to have an excitatory effect on the bitter taste receptor. The leaves of plants are mutant and agglutination tests for this compound show that it is a hexapeptide. H-D-Ile-OBzl·p-tosylate can be synthesized from erythritol and p-toluenesulfonyl chloride. The chemical data for this compound indicates that it has a molecular weight of 442.3 Da and the observed spectra indicate that it is a white solid with no charge.</p>Fórmula:C13H19NO2·C7H8O3SPureza:Min. 95%Peso molecular:393.5 g/mol(Deamino-Phe19,D-Ala24,D-Pro26-psi(CH2NH)Phe27)-GRP (19-27) (human, porcine, canine) trifluoroacetate salt
CAS:<p>Please enquire for more information about (Deamino-Phe19,D-Ala24,D-Pro26-psi(CH2NH)Phe27)-GRP (19-27) (human, porcine, canine) trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Fórmula:C57H72N14O8Pureza:Min. 95%Peso molecular:1,081.27 g/molβ-Amyloid (1-11)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C56H76N16O22Peso molecular:1,325.32 g/molDynorphin A (9-17), porcine
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C53H85N17O14Peso molecular:1,184.37 g/mol[Lys(Me3)4]-Histone H3 (1-21), H3K4(Me3)
<p>Custom research peptide; min purity 95%. For different specs please use the Peptide Quote Tool</p>Peso molecular:2,296.6 g/molα 1 Antichymotrypsin protein
<p>Alpha 1 Antichymotrypsin protein is a basic protein that plays a crucial role in the regulation of proteolytic activity. It acts as an inhibitor of chymotrypsin and other serine proteases, preventing excessive proteolysis in various physiological processes. This protein is known to interact with acidic proteins such as histidine-rich glycoprotein and annexin A2, forming complexes that modulate their functions. Additionally, Alpha 1 Antichymotrypsin protein has been shown to regulate the activity of growth factors like epidermal growth factor, contributing to cell proliferation and differentiation. In the field of Life Sciences, this protein is widely used in research studies involving low-density lipoproteins, collagen synthesis, fatty acid metabolism, and annexin biology. Its native form ensures optimal bioactivity and stability for reliable experimental results. Choose Alpha 1 Antichymotrypsin protein for your research needs and unlock new insights into cellular processes and disease</p>Pureza:Min. 95%AM 4668
CAS:<p>AM 4668 is a biochemical compound, which is derived from synthetic origins with complex organic synthesis processes. Its primary mode of action involves targeted enzymatic inhibition, effectively interacting with specific enzyme active sites to modulate biochemical pathways.</p>Fórmula:C24H19F3O4SPureza:Min. 95%Peso molecular:488.48 g/molBiotin-PACAP (1-38), amide, human, ovine, rat
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C203H331N63O53S1Peso molecular:4,534.24 g/mol[Des-Asp187]-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C42H67N9O12Peso molecular:890.06 g/molp60c-src Substrate I
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C44H60N8O11Peso molecular:877.01 g/molpro-ε-Tx1X/12
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C66H126N26O16Peso molecular:1,539.90 g/molCreatine phosphate monosodium salt hexahydrate
CAS:<p>Phosphate reservoir in muscles, aiding conversion of ADP to ATP</p>Fórmula:C4H10N3O5P·Na·6H2OCor e Forma:PowderPeso molecular:342.19 g/molAngiotensin I-Converting Enzyme Substrate
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C24H27N3O5Peso molecular:437.49 g/mol[His11]Substance P
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C64H96N20O13Peso molecular:1,353.60 g/molN-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C43H65O7N9Peso molecular:824.04 g/molNeo-Kyotorphin
CAS:<p>Catalogue peptide; min. 95% purity</p>Fórmula:C28H47N9O9Peso molecular:653.74 g/molSaposin C12
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C62H108N16O22Peso molecular:1,429.65 g/molβ-Interleukin II (44-56)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C68H113N19O19Peso molecular:1,500.77 g/molGKA 50
CAS:<p>Glucokinase activator</p>Fórmula:C26H28N2O6Pureza:Min. 95%Cor e Forma:White PowderPeso molecular:464.51 g/molCecropin P1 (porcine)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C147H253N46O43Peso molecular:3,338.93 g/molEGF Receptor (988-993) (phosphorylated) (human)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C31H46N7O16PPeso molecular:804.7 g/molFMRF amide Molluscan Cardioexcitatory Peptide
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C29H42N8O4SPeso molecular:598.76 g/molα-Helical CRF (9-41)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C166H274N46O53S2Peso molecular:3,826.44 g/molPLM derived peptide
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C49H96N24O12Peso molecular:1,213.47 g/molFas C-Terminal Tripeptide
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C16H29N3O6Peso molecular:359.43 g/mol[Cys0]-GTP-Binding Protein Gsa (28-42)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C85H143N30O24SPeso molecular:2,001.29 g/molFITC-LC-Myelin Basic Protein Peptide Substrate
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C66H92N20O17SPeso molecular:1,325.4 g/molRuxolitinib phosphate
CAS:Produto Controlado<p>Ruxolitinib is a janus tyrosine kinase inhibitor active specifically on sub-types JAK1 and JAK2 with IC50 values in the nanomolar range. JAK1 and JAK2 are kinases involved in the regulation of hematopoiesis. Clinically applied to the treatment of intermediate and high-risk myelofibrosis, ruxolitinib is usually well tolerated by patients.</p>Fórmula:C17H18N6•H3O4PPureza:Min. 95%Peso molecular:404.36 g/mol26Rfa, Hypothalamic Peptide, frog
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C127H197N37O36Peso molecular:2,818.21 g/molRnase (90-105)
<p>H-SKYPNCAYKTTQANKH-OH peptide, corresponding to RNase A 90-105 (Chain A of bovine pancreatic ribonuclease); min. 95% purity</p>Fórmula:C80H124N24O25SPeso molecular:1,854.08 g/molSeglitide acetate
CAS:Produto Controlado<p>Seglitide is a cyclic peptide that is a model system for the receptor activity of somatostatin. Somatostatin inhibits cells by binding to its receptors, which are found on the surface of endocrine cells and in the hypothalamus. Seglitide has been shown to inhibit cell growth in tissue culture and is a potent inhibitor of epidermal growth factor (EGF) production. Seglitide also activates locomotor activity in mice, suggesting that it may have some clinical relevance. Structural analysis has revealed that seglitide's amino acid sequence is similar to somatostatin's, making them closely related compounds. It also binds to DNA-dependent RNA polymerase, preventing transcription and replication.</p>Fórmula:C44H56N8O7·C2H4O2Pureza:Min. 95%Peso molecular:869.02 g/molSMN-C3
CAS:<p>SMN-C3 is a synthetic compound designed specifically as a targeted therapeutic agent. It is derived through advanced chemical synthesis techniques, utilizing a meticulous approach to optimize efficacy and specificity. The mode of action of SMN-C3 involves precise interaction with select molecular targets, thereby modulating biological pathways with high specificity. This interaction is designed to alter the course of disease processes, offering potential therapeutic benefits.</p>Fórmula:C24H28N6OPureza:Min. 95%Peso molecular:416.5 g/mol[D-Pro4,D-Trp7,9,Nle11]-Substance P (4-11)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C58H77N13O10Peso molecular:1,116.34 g/molMyristoylated Protein Kinase C (19-31)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C81H144N26O26Peso molecular:1,754.23 g/molProdynorphin (228-256), porcine
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C161H236N42O48Peso molecular:3,527.93 g/molα-Melanocyte Stimulating Hormone [Met5, Pro6, D-Phe7, D-Trp9, Phe10] (5-13) (MSHa)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C61H87N15O9SPeso molecular:1,206.53 g/molAdrenomedullin (1-52), human
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C264H406N80O77S3Peso molecular:6,028.72 g/molMMP Biotinylated Substrate I
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C53H86N14O11Peso molecular:1,127.43 g/molGLP-2 (rat)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C166H256N44O56SPeso molecular:3,796.22 g/mol[Lys4] Sarafotoxin S6c
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C105H153N27O36S5Peso molecular:2,529.87 g/molR-G-D-S-P-A-S-S-K-P
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C40H68N14O16Peso molecular:1,001.07 g/molAmyloid Bri Protein (1-34)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C173H273N49O52S2Peso molecular:3,935.55 g/molSelectin
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C62H105N16O18S2Peso molecular:1,426.75 g/molCecropin A (1-7)-Melittin A (2-9) amide
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C89H152N22O15Peso molecular:1,770.34 g/molBiotin-Angiotensin I, human
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C72H103N19O16SPeso molecular:1,522.81 g/molBiotin-Amyloid β-Protein (1-42)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C213H325N57O62S2Peso molecular:4,740.44 g/molPlatelet-Derived Growth Factor Receptor Substrate 1
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C52H81N12O19PPeso molecular:1,209.29 g/molHypercalcemia Malignancy Factor (1-40)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C180H287N57O48Peso molecular:4,017.55 g/molHPV-E7-N
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C108H159N23O39S2Peso molecular:2,467.72 g/mol[Arg14,20,21, Leu16]-PACAP (1-27)-Gly-Lys-Arg, amide, human, ovine, rat
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C157H253N53O42Peso molecular:3,555.01 g/molBiotinyl-MCH (salmon)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C99H153N29O26S5Peso molecular:2,325.82 g/molInsulin Receptor (1142-1153)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C72H107N19O24Peso molecular:1,622.77 g/molγ-Neuropeptide, rabbit
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C99H158N34O29SPeso molecular:2,320.64 g/molBiotin-Tyrosine Kinase Peptide 1, amide
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C87H139N21O24SPeso molecular:1,895.27 g/molVasoactive Intestinal Constractor [VIC]
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C116H161N27O32S4Peso molecular:2,574 g/molInfluenza HA (529-537)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C41H67N9O13Peso molecular:894.04 g/mol[APLILSR]pPSA
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C80H131N21O22SPeso molecular:1,771.12 g/molRF-amide peptide, Drosophila
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C58H86N16O15Peso molecular:1,247.43 g/molCrustacean Erythrophore Concentrating Hormone
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C45H59N11O11Peso molecular:930.04 g/mol[D-Tyr6, β-Ala11, β-Phe13, Nle14]-Bombesin
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C81H115N23O18Peso molecular:1,698.98 g/mol[Ala144]-PLP (139-151) A144-PLP(139-151)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C64H99N19O17Peso molecular:1,406.62 g/molAcyl Carrier Protein (65-74) (amide)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C47H75N13O15Peso molecular:1,062.20 g/molMARCKS Substrate (151-175)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C147H246N41O40P3Peso molecular:3,320.78 g/molAdipokinetic Hormone II Locusta Migratoria
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C43H57N11O11Peso molecular:904.02 g/molGastric Inhibitory Polypeptide (1-30) (porcine)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C162H244N40O48SPeso molecular:3,551.97 g/molEndokinin A/B
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C50H77N13O12SPeso molecular:1,084.32 g/mol[D-Ala2]-β-Casomorphin (1-5), bovine
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C28H35N5O7Peso molecular:553.6 g/molIGF-II (33-40)
CAS:<p>This is a synthetic IGF-II peptide fragment (33-40) that has been immunized with an antiserum against the human growth hormone. It is used to measure the level of IGF-II in blood or serum. The immunizing antiserum cross-reacts with IgF-I and can also be used as a control for deficiency.</p>Fórmula:C38H74N20O12Pureza:Min. 95%Peso molecular:1,003.12 g/molP69 (522-534), M. leprae
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C52H84N14O21Peso molecular:1,241.33 g/molcAMP Dependent PK Inhibitor (5-22), amide
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C84H137N29O26Peso molecular:1,969.16 g/molIntermedin-53 (human)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C247H397N83O73S3Peso molecular:5,793.61 g/molp3K, (Lys 58 Lys 60 Lys 63) Ea(52-68)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C77H129N23O25Peso molecular:1,777.03 g/molMinigastrin I (human)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C74H99N15O26SPeso molecular:1,645.66 g/mol[D-Ala2]-beta-Casomorphin (1-5) amide (bovine)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C28H36N6O6Peso molecular:552.64 g/mol[Pyr4]-MBP (4-14)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C60H100N20O17Peso molecular:1,391.61 g/mol[D-Leu2]-Melanocyte-Stimulating Hormone-Release Inhibiting Factor
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C13H24N4O3Peso molecular:284.36 g/mol[Asn670,Leu671]-Amyloid β/A4 Protein Precursor770 (667-675)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C44H66N10O18Peso molecular:1,023.07 g/molBAD (103-127), human
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C137H212N42O39SPeso molecular:3,103.54 g/mol[D-Ser14]-Humanin (HN)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C119H204N34O32S2Peso molecular:2,687.28 g/molLeucokinin IV
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C41H52N12O12Peso molecular:904.9 g/mol[D-Phe11]-Neurotensin
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C78H121N21O19Peso molecular:1,657 g/molβ-Amyloid (1-33)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C164H242N46O51Peso molecular:3,673.94 g/mol[Tyr11]-Somatostatin
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C76H102N18O20S2Peso molecular:1,651.91 g/molHelodormin
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C176H285N47O49Peso molecular:3,843.47 g/molBone Matrix Proteins
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C40H67N13O14Peso molecular:954.06 g/molCathepsin S substrate
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C41H66N12O9Peso molecular:871.08 g/molPACAP-38 (28-38) (human, chicken, mouse, ovine, porcine, rat)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C61H110N24O14Peso molecular:1,403.71 g/molPreprogalanin 28-67, rat
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C198H312N62O58Peso molecular:4,488.96 g/mol[Tyr1]-Adipokinetic Hormone, locust
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C58H78N14O15Peso molecular:1,211.5 g/molBiotin-Obestatin (human)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C126H190N34O35Peso molecular:2,773.19 g/molDynorphin A (2-17), porcine
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C90H146N30O21Peso molecular:1,984.36 g/molβ-Amyloid Protein Precursor (657-676)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C95H152N30O31Peso molecular:2,210.45 g/molAc-Adhesin (1025-1044) amide
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C97H160N26O32Peso molecular:2,202.51 g/molAldosterone Secretion Inhibiting Factor (1-35) (bovine)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C164H278N58O45S4Peso molecular:3,910.64 g/mol[Trp11]-Neurotensin
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C80H122N22O19Peso molecular:1,696 g/molCalcium/Calmodulin Dependent Protein Kinase II-g (345-358)
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C58H107N21O22Peso molecular:1,450.63 g/molEndothelin-1 (1-15), human
<p>Catalogue peptide; min. 95% purity</p>Fórmula:C70H108N16O24S5Peso molecular:1,718.02 g/mol1-(Carboxymethyl)-1H-benzo[G]indole-2-carboxylic acid
CAS:<p>Please enquire for more information about 1-(Carboxymethyl)-1H-benzo[G]indole-2-carboxylic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Fórmula:C15H11NO4Pureza:Min. 95%Peso molecular:269.25 g/molLHRH (1-5) (free acid) trifluoroacetate salt
CAS:<p>LHRH (1-5) (free acid) trifluoroacetate salt is a synthetic hormone that is used in the treatment of prostate cancer. It inhibits the release of luteinizing hormone and follicle-stimulating hormone from the anterior pituitary gland, which suppresses testosterone production by the testes. LHRH (1-5) (free acid) trifluoroacetate salt is synthesized industrially using a liquid phase synthesis. The product may be recycled by returning it to the manufacturing process or using it as an additive for plastics or other industrial products. LHRH (1-5) (free acid) trifluoroacetate salt was shown to be active against tumor cells in culture and inhibited cell growth in culture. This drug has been shown to inhibit the production of nitric oxide, which may contribute to its anti-tumor activity. LHRH (1-5) (free acid)</p>Fórmula:C34H38N8O9Pureza:Min. 95%Cor e Forma:PowderPeso molecular:702.71 g/molH-GILGFVFTL-OH
CAS:<p>FluM1 (58-66) is a short part of the matrix protein of Influenza A virus which is the most abundant component of this enveloped virus localized under the viral lipid envelope. The GILGFVFTL epitope is highly conserved in Influenza A virus strains at a rate of 93% for 69 strains tested. Human Influenza epitopes may bind MHC molecules and then may be recognized by CD8+ cytotoxic T cells. Applications of FluM1 (58-66): FluM1 (58-66) is used to stimulate CTL responses in peripheral blood mononuclear cells (PBMCs). Then, ELISPOT assay is used to quantify peptide epitope specificity and IFN-γ releasing effector cells. FluM1 (58-66) has shown CTL responses qualified of immunodominant with restriction by HLA-A*02:01. It has also been detected CTL responses when FluM1 (58-66) is restricted by all HLA-C. Therefore, FluM1 (58-66) may help to understand the reaction of immune system against Influenza virus of each populations having different HLA type. FluM1 (58-66) has indeed prompted research to develop T-cell vaccine strategies capable of inducing specific CTL responses in patients upon immunization with Influenza M1 antigenic epitope. MVA-NP+M1 vaccine use GILGFVFTL epitope and is tested in clinical trial. Potential cross-reactivity with HIV-1 p17 Gag (77-85): Moreover, FluM1 (58-66) share similarities with HIV-1 p17 Gag (77-85) which can potentially show a cross-reactivity between these epitopes. It has been demonstrated a cross-reactivity and results suggest that immunity following infection by Influenza virus causes specific immune response to HIV-1 p17 Gag (77-85).</p>Fórmula:C49H75N9O11Peso molecular:966.18 g/molVancomycin methyl ester
CAS:<p>Vancomycin methyl ester is an analog of the antibiotic vancomycin that has been shown to have anticancer properties. It induces apoptosis in cancer cells, particularly in Chinese hamster ovary (CHO) cells and human tumor cell lines. Vancomycin methyl ester acts as a cyclin-dependent kinase inhibitor by binding to the ATP-binding site of these kinases, thereby inhibiting their activity. This protein kinase inhibition leads to the downregulation of proteins involved in cell cycle progression, such as cyclin D1 and E2F1, ultimately leading to cell death. Vancomycin methyl ester has also been found to inhibit the growth of certain types of cancer cells by blocking angiogenesis, which is the formation of new blood vessels that tumors need for their growth and survival. Additionally, this compound has been detected in human urine after administration and may have potential therapeutic applications in cancer treatment.</p>Fórmula:C67H77Cl2N9O24Pureza:Min. 95%Peso molecular:1,463.3 g/mol16:0-23:2 Diyne pe
CAS:<p>Diynes are a group of unsaturated fatty acids that have two carbon-carbon double bonds. 16:0-23:2 Diyne pe is a growth factor that has been shown to increase the proliferation of prostate cancer cells in vitro. It has also been shown to stimulate angiogenesis, or the formation of new blood vessels from pre-existing ones. It has been found to be an important prognostic factor for cervical cancer and may be used as a predictive marker for prognosis and treatment. This compound is present in human serum at low levels and is increased by liver damage, inflammation, or other diseases such as hepatitis. 16:0-23:2 Diyne pe may also play a role in preeclampsia and cell culture, where it stimulates cell proliferation. In addition, this compound may act as a receptor for fatty acid metabolism.</p>Fórmula:C44H80NO8PPureza:Min. 95%Peso molecular:782.08 g/molCA 125 antibody (biotin)
<p>CA 125 antibody (biotin) was raised in mouse using affinity pure human CA 125 antigen as the immunogen.</p>GC-globulin from human plasma
CAS:<p>GC-globulin is a protein that is found in human plasma. It can be used as an activator, inhibitor, or ligand for ion channels, receptors, and other proteins. GC-globulin has been shown to inhibit the function of receptor tyrosine kinases on B-cells with antibodies that bind to the Fc region of the protein. This inhibition prevents activation of the B-cell receptor and thus inhibits antibody production by B cells. GC-globulin also binds to peptides during cell division and functions as a cofactor for proteolytic enzymes such as plasminogen activator (PA). GC-globulin has been shown to activate PA which leads to fibrinolysis.</p>Pureza:Min. 95%Siratiazem
CAS:<p>Siratiazem is a calcium-channel blocker that is used for the treatment of cardiac arrhythmia and hypertension, as well as for the prevention of congestive heart failure. Siratiazem is a prodrug that is converted to its active form by hydrolysis in the liver. It binds to the L-type calcium channels in cardiac muscle cells, thereby blocking calcium influx and decreasing the excitability of these cells. This drug has been shown to be effective in phase 1 clinical trials, with no major adverse effects. Siratiazem can cause symptoms such as nausea, vomiting, diarrhea, or constipation and may also have effects on insulin resistance and ventricular dysfunction.</p>Fórmula:C24H30N2O4SPureza:Min. 95%Peso molecular:442.57 g/molIsodesmosine
CAS:<p>Isodesmosine is an amino acid and naturally occurring cross-linking compound, which is primarily found in elastin, a key protein in connective tissues. Its source is the structural protein elastin, where it forms stable cross-links that contribute to the elasticity and resilience of various tissues, notably the skin, lungs, and blood vessels. The mode of action of isodesmosine involves its integration into the elastin matrix, providing durability and elasticity through covalent bonding within and between polypeptide chains.</p>Fórmula:C24H40N5O8Pureza:Min. 95%Peso molecular:526.6 g/molPI3K-γ inhibitor 1
CAS:<p>PI3K-gamma inhibitor 1 is a small molecule inhibitor, which is selectively synthesized for targeting the PI3K-gamma isoform. This inhibitor is derived through precise medicinal chemistry, involving the synthesis of compounds that specifically interact with the catalytic domain of the phosphoinositide 3-kinase gamma (PI3K-γ) enzyme. Its mode of action involves the selective inhibition of the PI3K-γ pathway, a critical signaling route responsible for modulating immune cell functions and inflammatory responses.</p>Fórmula:C32H26N8O2SPureza:Min. 95%Peso molecular:586.67 g/mol(Pyr³)-Amyloid B-protein (3-42) trifluoroacetate
CAS:<p>Please enquire for more information about (Pyr³)-Amyloid B-protein (3-42) trifluoroacetate including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Fórmula:C196H299N53O55S•(C2HF3O2)xPureza:Min. 95 Area-%Z-VRPR-FMK trifluoroacetate
CAS:<p>Z-VRPR-FMK trifluoroacetate is an apoptosis-inducing inhibitor that works by inhibiting a specific kinase in the human body. It has been shown to have anti-cancer properties and may be useful in the treatment of various types of cancer. Z-VRPR-FMK trifluoroacetate is a menthol analog that acts as an inhibitor of apoptosis, which is the process by which cells die naturally. This compound has been tested on Chinese hamster ovary cells and has been found to be effective at inducing apoptosis in these cells. Additionally, Z-VRPR-FMK trifluoroacetate has been shown to inhibit tylosin-induced apoptosis in human colon cancer cells. Overall, this compound shows promise as a potential therapeutic agent for the treatment of cancer and other diseases.</p>Fórmula:C34H50F4N10O9Pureza:Min. 95%Peso molecular:818.8 g/molUM729
CAS:<p>UM729 is an advanced surface coating, which is a chemical formulation with the aim of enhancing surface durability and protection. Sourced from novel polymeric materials, UM729 is designed to form a robust and resilient layer when applied to various substrates. Its mode of action involves cross-linking at the molecular level, creating a cohesive barrier that offers resistance to environmental factors such as abrasion, moisture, and UV radiation.</p>Fórmula:C20H25N5O2Pureza:Min. 95%Peso molecular:367.44 g/molCefuroxime-d3
CAS:<p>Cefuroxime-d3 is intended for use as an internal standard for the quantification of cefuroxime, FA19881. Cefuroxime is a cephalosporin antibiotic with broad-spectrum activity against Gram-positive and Gram-negative bacteria.</p>Fórmula:C16H16N4O8SPureza:Min. 95%Peso molecular:427.4 g/mol3-Bromo-L-thyroxine
CAS:<p>Please enquire for more information about 3-Bromo-L-thyroxine including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Fórmula:C15H11BrI3NO4Pureza:Min. 95%Peso molecular:729.87 g/mol3-Indolepropionyl-coa
CAS:<p>3-Indolepropionyl-coa is a potent inhibitor of cancer cell cycle and has been found to induce apoptosis in human cancer cells. This compound is an analog of the naturally occurring urinary metabolite, indole-3-acetic acid, which has been shown to have anticancer properties. 3-Indolepropionyl-coa is a promising medicinal compound for the development of novel anticancer drugs due to its ability to inhibit protein kinase activity in Chinese hamster ovary cells. It has also been reported to inhibit tumor growth and proliferation by blocking the production of cyclin-dependent kinases, which are essential for cell division. The potential use of 3-Indolepropionyl-coa as a therapeutic agent for cancer treatment warrants further investigation.</p>Fórmula:C32H45N8O17P3SPureza:Min. 95%Peso molecular:938.7 g/molFAPI-46 trifluoroacetate
CAS:<p>FAPI-46 trifluoroacetate is a fibroblast activation protein (FAP) inhibitor, which is synthesized as part of targeted cancer research efforts. It is derived from chemical engineering processes focusing on the modification of small molecules to selectively interact with FAP, an enzyme overexpressed in cancer-associated fibroblasts (CAFs) within the tumor microenvironment. FAPI-46 binds to and inhibits FAP, reducing its enzymatic activity. By blocking FAP, FAPI-46 trifluoroacetate disrupts the tumor-promoting interactions between CAFs and tumor cells, potentially impeding tumor growth and progression.</p>Fórmula:C41H57F2N11O9•(C2HF3O2)xPureza:Min. 95%LY 117018
CAS:<p>LY 117018 is a dopamine analog that binds to the toll-like receptor and blocks the production of proinflammatory cytokines. LY 117018 also inhibits epidermal growth factor (EGF) in liver cells and cyclin D2, which is involved in cell cycle regulation. This drug has been shown to be effective in a model system using fetal bovine serum with angiogenic factors, such as vascular endothelial growth factor (VEGF). The effect on blood vessels was dose-dependent for LY 117018. This drug potentiates the actions of 17β-estradiol on mcf-7 cells and serum prolactin levels are significantly decreased in vivo by this compound.</p>Fórmula:C27H25NO4SPureza:Min. 95%Peso molecular:459.6 g/molCrotonyl coenzyme A
CAS:<p>Involved in the metabolism of fatty acids and amino acids</p>Fórmula:C25H40N7O17P3SPureza:Min. 95%Peso molecular:835.6 g/molCagrilintide
CAS:<p>Please enquire for more information about Cagrilintide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>18:0 PE-DTPA
CAS:<p>18:0 PE-DTPA is a cationic amphiphile that is composed of 18:0 phosphatidylethanolamine (PE) and DTPA. It has a strong affinity for gadolinium, which is used in MRI imaging. 18:0 PE-DTPA micelles are used to deliver gadolinium to the target site where it accumulates inside cells. The accumulation of gadolinium in cells can be detected by MRI.</p>Fórmula:C55H103N4O17PPureza:Min. 95%Peso molecular:1,123.4 g/molRetroprogesterone
CAS:Produto Controlado<p>Retroprogesterone is a human urine-derived compound that has shown promising results in the field of cancer research. It is an analog of oseltamivir and acts as a kinase inhibitor, which makes it an effective anticancer agent. Retroprogesterone has been shown to induce apoptosis in cancer cells by inhibiting protein kinases that are essential for cell survival and proliferation. This compound has demonstrated potent tumor growth inhibition in Chinese hamster ovary cells, making it a potential candidate for cancer therapy. Retroprogesterone has also been studied as an inhibitor of various kinases involved in cancer development and progression. Its ability to target multiple pathways involved in cancer makes it a valuable tool for future research and drug development.</p>Fórmula:C21H30O2Pureza:Min. 95%Cor e Forma:PowderPeso molecular:314.5 g/molCerebellin trifluoroacetate
CAS:<p>Please enquire for more information about Cerebellin trifluoroacetate including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Fórmula:C69H113N23O23•(C2HF3O2)4Pureza:Min. 95%Peso molecular:2,088.86 g/mol3-Amino-6,7,8,9-tetrahydro-5H-1-thia-10-aza-cyclohepta[f]indene-2-carboxylic acid (5-phenyl-[1,3,4]thiadiazol-2-yl)-amide
CAS:<p>This peptide is a research tool that has been shown to activate the ATP-sensitive potassium ion channel, which is found in the membranes of many cells. This peptide also binds to the beta2-adrenergic receptor and has been shown to inhibit the activity of protein kinase C. The CAS number for this peptide is 400863-77-6.</p>Fórmula:C21H19N5OS2Pureza:Min. 95%Peso molecular:421.5 g/molSermorelin acetate
CAS:Produto Controlado<p>Sermorelin acetate is a synthetic peptide, which is an analogue of the naturally occurring growth hormone-releasing hormone (GHRH). It is derived from recombinant DNA technology, representing the first 29 amino acids (1-29) of endogenous GHRH. Its mode of action involves binding to and activating the GHRH receptor on the anterior pituitary gland, which subsequently stimulates the release of growth hormone (GH) into the bloodstream.</p>Fórmula:C149H246N44O42S·C2H4O2Pureza:Min. 95%Peso molecular:3,417.94 g/molThymopentin acetate salt
CAS:Produto Controlado<p>Thymopentin acetate salt H-Arg-Lys-Asp-Val-Tyr-OH acetate salt is an experimental model system that has been shown to replicate the physiological effects of thymopoietin in vitro. It has also been shown to inhibit the growth of Candida glabrata, a fungus that causes infection in patients with HIV or AIDS. Thymopentin acetate salt H-Arg-Lys-Asp-Val-Tyr-OH acetate salt has been shown to activate both toll like receptor and IL2 receptor, which may be due to its ability to stimulate polyamine synthesis.</p>Fórmula:C30H49N9O9Pureza:Min. 95%Peso molecular:679.77 g/molBenzoylecgonine antibody
<p>Benzoylecgonine antibody was raised in mouse using benzoyl ecgonine-BSA as the immunogen.</p>Pureza:Min. 95%Kotalanol
CAS:<p>Alpha-glucosidase inhibitor; anti-diabetic</p>Fórmula:C12H24O12S2Pureza:Min. 95%Peso molecular:424.44 g/molEthyl N,N,N',N'-Tetraisopropylphosphorodiamidite
CAS:<p>Please enquire for more information about Ethyl N,N,N',N'-Tetraisopropylphosphorodiamidite including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Fórmula:C14H33N2OPPeso molecular:276.4 g/molMethotrexate antibody
<p>The Methotrexate antibody is a monoclonal antibody that specifically targets and binds to Methotrexate, a commonly used cytotoxic drug in the field of Life Sciences. This antibody has been extensively tested and validated for its high affinity and specificity towards Methotrexate. It can be used in various applications such as ELISA, Western blotting, immunohistochemistry, and flow cytometry. The Methotrexate antibody works by binding to Methotrexate molecules and preventing their interaction with their target enzymes involved in DNA synthesis. This inhibits the growth of cancer cells and autoimmune responses mediated by activated T-cells. Additionally, this antibody can also be utilized as a tool for studying the intracellular localization and trafficking of Methotrexate within cells. The unique features of this Methotrexate antibody include its ability to recognize both free Methotrexate molecules as well as Methotrexate conjugated to proteins or other biomolecules. It exhibits minimal cross-reactivity with</p>Opiorphin trifluoroacetate
CAS:<p>Please enquire for more information about Opiorphin trifluoroacetate including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Fórmula:C29H48N12O8•(C2HF3O2)xPureza:Min. 95%Aptiganel
CAS:<p>Aptiganel (CAS No. 137159-92-3) is a research tool that can be used to study the interaction of proteins and peptides with ion channels. It is an inhibitor of ion channels that blocks the flow of ions through them, thereby preventing the generation of action potentials. Aptiganel is a potent inhibitor of voltage-dependent calcium channels, which are found in neurons and muscle cells. This drug binds to ligands on the extracellular side of ion channel receptors and prevents ligand binding to the receptor, blocking ion flow. Aptiganel has been shown to inhibit voltage-gated potassium channels in rat dorsal root ganglion cells, human neuroblastoma cells grown in culture, and cultured mouse embryo spinal cord neurons. Aptiganel also inhibits voltage-gated sodium channels in rat dorsal root ganglion cells and cultured mouse embryo spinal cord neurons.</p>Fórmula:C20H21N3Pureza:Min. 95%Peso molecular:303.4 g/molALX-1393
CAS:<p>ALX-1393 is a synthetic compound that acts as an inhibitor, specifically targeting the glycine transporter 1 (GlyT1). As a small molecule inhibitor derived from chemical synthesis, it modulates neurotransmitter systems by blocking the reuptake of glycine, an important co-agonist of the NMDA receptor, in the central nervous system. The mode of action of ALX-1393 involves binding to the GlyT1 transporter, thereby increasing the synaptic concentration of glycine. This elevation in glycine levels enhances NMDA receptor function, which is crucial for synaptic plasticity, learning, and memory.</p>Fórmula:C23H22FNO4Pureza:Min. 95%Peso molecular:395.4 g/mol1-Palmitoyl-rac-glycero-3-phosphocholine
CAS:<p>1-Palmitoyl-rac-glycero-3-phosphocholine is a biological lipid that has been shown to be a potent growth factor for cells in culture. It binds to DNA and modulates transcriptional regulation. 1-Palmitoyl-rac-glycero-3-phosphocholine also inhibits the production of lysophosphatidylcholine, which is an inflammatory mediator that promotes the release of histamine from mast cells. This compound may be useful as an antimicrobial agent, as it has been shown to inhibit the growth of bacteria and fungi.</p>Fórmula:C24H50NO7PPureza:Min. 95%Peso molecular:495.63 g/mol2-Benzyl-2,8-diazaspiro[4.5]decan-1-one hydrochloride
CAS:<p>2-Benzyl-2,8-diazaspiro[4.5]decan-1-one hydrochloride is a chemical compound utilized chiefly in pharmacological research. It is synthesized through organic chemical processes designed to produce spirocyclic frameworks that can interact specifically with biological macromolecules. The compound acts as a ligand in receptor studies, allowing researchers to investigate the binding properties and activities at selective receptor subtypes.</p>Fórmula:C15H20N2O•HClPureza:Min. 95%Peso molecular:280.79 g/molPF2562
CAS:<p>PF2562 is a potent and selective activator of the metabotropic glutamate receptor mGluR5. It is a competitive antagonist at AMPA receptors, with no activity at NMDA or kainate receptors. PF2562 is known to inhibit protein interactions between the proteins encoded by the gene for the metabotropic glutamate receptor mGluR5 and its ligands, such as l-glutamic acid and d-serine. This inhibition leads to activation of these receptors, which may be important in research on neurological disorders and other diseases involving glutamate signaling.</p>Fórmula:C19H17N5OPureza:Min. 95%Peso molecular:331.4 g/molhCG protein
<p>The hCG protein is a growth factor that plays a crucial role in various biological processes. It is involved in the regulation of cell growth, differentiation, and development. This protein has been extensively studied in the field of Life Sciences and has shown promising results in various applications. One of the key characteristics of the hCG protein is its ability to interact with arginase, an enzyme involved in the metabolism of arginine. Through molecular docking studies, it has been shown that hCG can bind to arginase and modulate its activity, leading to potential therapeutic applications. Monoclonal antibodies targeting the hCG protein have been developed for research purposes. These antibodies are highly specific and can be used in immunoassays to detect and quantify hCG levels in human serum samples. They have also been used for the immobilization of hCG on electrodes, enabling the development of biosensors for diagnostic purposes. Furthermore, studies have demonstrated that the hCG protein plays a role in the regulation of mes</p>Pureza:Min. 95%Oligopeptide-51
<p>Please enquire for more information about Oligopeptide-51 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Pureza:Min. 95%H-Leu-Leu-Gly-OH trifluroacetate
CAS:<p>Please enquire for more information about H-Leu-Leu-Gly-OH trifluroacetate including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Fórmula:C14H27N3O4•C2HF3O2Pureza:Min. 95%Peso molecular:415.4 g/mol
![[Pyr11]-Amyloid β-Protein (11-40)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00202.webp&w=3840&q=75)
![[Ala2] Met-Enkephalin, amide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00854.webp&w=3840&q=75)
![[Des-Gln16]-PACAP (6-27), amide, human, ovine, rat](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00400.webp&w=3840&q=75)
![[Asn76] PTH (64-84), human](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00372.webp&w=3840&q=75)
![[D-Arg1,D-Pro2,D-Phe7,D-His9]-Substance P](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00149.webp&w=3840&q=75)
![[Lys(Me3)4]-Histone H3 (1-21), H3K4(Me3)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FPP50506.webp&w=3840&q=75)
![[Des-Asp187]-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00513.webp&w=3840&q=75)
![[His11]Substance P](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00676.webp&w=3840&q=75)
![[Cys0]-GTP-Binding Protein Gsa (28-42)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00280.webp&w=3840&q=75)
![[D-Pro4,D-Trp7,9,Nle11]-Substance P (4-11)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00148.webp&w=3840&q=75)
![α-Melanocyte Stimulating Hormone [Met5, Pro6, D-Phe7, D-Trp9, Phe10] (5-13) (MSHa)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00606.webp&w=3840&q=75)
![[Lys4] Sarafotoxin S6c](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00293.webp&w=3840&q=75)
![[Arg14,20,21, Leu16]-PACAP (1-27)-Gly-Lys-Arg, amide, human, ovine, rat](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00488.webp&w=3840&q=75)
![Vasoactive Intestinal Constractor [VIC]](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00287.webp&w=3840&q=75)
![[APLILSR]pPSA](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00239.webp&w=3840&q=75)
![[D-Tyr6, β-Ala11, β-Phe13, Nle14]-Bombesin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00196.webp&w=3840&q=75)
![[Ala144]-PLP (139-151) A144-PLP(139-151)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00493.webp&w=3840&q=75)
![[D-Ala2]-β-Casomorphin (1-5), bovine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00829.webp&w=3840&q=75)
![[D-Ala2]-beta-Casomorphin (1-5) amide (bovine)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00828.webp&w=3840&q=75)
![[Pyr4]-MBP (4-14)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00186.webp&w=3840&q=75)
![[D-Leu2]-Melanocyte-Stimulating Hormone-Release Inhibiting Factor](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00620.webp&w=3840&q=75)
![[Asn670,Leu671]-Amyloid β/A4 Protein Precursor770 (667-675)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00713.webp&w=3840&q=75)
![[D-Ser14]-Humanin (HN)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00594.webp&w=3840&q=75)
![[D-Phe11]-Neurotensin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00191.webp&w=3840&q=75)
![[Tyr11]-Somatostatin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00218.webp&w=3840&q=75)
![[Tyr1]-Adipokinetic Hormone, locust](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00892.webp&w=3840&q=75)
![[Trp11]-Neurotensin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00192.webp&w=3840&q=75)
![1-(Carboxymethyl)-1H-benzo[G]indole-2-carboxylic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FAAC27331.webp&w=3840&q=75)
![3-Amino-6,7,8,9-tetrahydro-5H-1-thia-10-aza-cyclohepta[f]indene-2-carboxylic acid (5-phenyl-[1,3,4…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FARA86377.webp&w=3840&q=75)
![2-Benzyl-2,8-diazaspiro[4.5]decan-1-one hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVSB16608.webp&w=3840&q=75)
